KWMG
MYGN icon

King Wealth Management Group’s Myriad Genetics MYGN Stock Holding History

King Wealth Management Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$113K – 163
2020
Q2 		$113K Buy
+10,000
New +$142K 0.03% 150

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

King Wealth Management Group's MYGN Position: Q3 2020 in Review

King Wealth Management Group sold out of Myriad Genetics (MYGN) in Q3 2020, closing a stake of 10,000 shares — an estimated $113K sold.

King Wealth Management Group first reported a position in MYGN in Q2 2020 and held it in 1 quarter. The position peaked at $113K in Q2 2020. 192 funds tracked by Wall St. Rank hold MYGN as of Q3 2020.

  • King Wealth Management Group reported no remaining Myriad Genetics position as of Q3 2020 after selling out during the quarter.
  • King Wealth Management Group sold 10,000 Myriad Genetics shares in Q3 2020, an estimated $113K.
  • King Wealth Management Group first reported a position in Myriad Genetics in Q2 2020 and held it in 1 quarter.
  • King Wealth Management Group's Myriad Genetics position peaked at $113K in Q2 2020.
  • 192 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2020.

Based on King Wealth Management Group's 13F filing for Q3 2020, filed 12 Nov 2020.